Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Forest Laboratories, Inc. Stockholders
February 18 2014 - 5:01PM
Business Wire
Kirby McInerney LLP is investigating potential claims against
the Board of Directors of Forest Laboratories, Inc. (“Forest” or
the “Company”) (NYSE:FRX) concerning the proposed acquisition of
the Company by Actavis plc (“Actavis”) (NYSE:ACT). Under the terms
of the definitive merger agreement, Forest stockholders will
receive $26.04 in cash and 0.3306 Actavis shares for each share of
Forest common stock owned, valuing the transaction at approximately
$25 billion.
The investigation concerns whether the Forest Board of Directors
violated its fiduciary duties by agreeing to the proposed
transaction and whether the proposed consideration adequately
values Forest’s common stock.
If you are a Forest stockholder and wish to obtain additional
information, please contact J. Brandon Walker, Esq. by email
at bwalker@kmllp.com, by telephone at (212) 699-1145 or (888)
529-4787, or by filling out this contact form. There is no cost or
obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating
in securities, shareholder, whistleblower, antitrust and consumer
litigation. For additional information, please go to
www.kmllp.com.
Kirby McInerney LLPJ. Brandon Walker, Esq.,
212-699-1145888-529-4787bwalker@kmllp.com
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024
